• Home
  • News
  • Portfolio News
  • Purdue Pharma taps TetraGenetics for ion channel-focused pain treatments in $273M discovery pact

Purdue Pharma taps TetraGenetics for ion channel-focused pain treatments in $273M discovery pact

27Feb

Purdue Pharma taps TetraGenetics for ion channel-focused pain treatments in $273M discovery pact

Portfolio News
Purdue Pharma’s newly formed clinical research subsidiary, Imbrium Therapeutics, has tapped TetraGenetics and its antibody discovery platform to help it develop new, non-opioid-based biologics for treating chronic pain. Read more >>

Share this post

Related Posts

15Sep

A Better Surgical Suture: A Development Story

The EasyWhip is indicated for use in approximation and/or ligation of soft tissues, including the use of allograft tissue for... read more
09Apr

MedCity INVEST unveils health IT startups selected for Pitch Perfect competition

The MedCity INVEST conference brings together investors and executives from healthcare organizations with promising startups in the biopharma, diagnostics, medical... read more
01Jun

Best Tech of 2017 So Far (eSight)

xThere's a growing consensus among the technological cognoscenti that we're in a "boring" period for gadgets. Some have long argued... read more
19Mar

Myomo, Inc., to Present at the New York City based Investor Summit on March 25th-26th

A wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, will be... read more
08Apr

Wasabi Technologies Partners with the Boston Red Sox Through Multi-Year Sponsorship Deal with Fenway Sports Group

Wasabi Technologies, the hot cloud storage company, today announced a multi-year partnership with Fenway Sports Group that harnesses the power... read more
24Nov

Stem Cell Agency Board Invests in Therapy Targeting Deadly Blood Cancers

Hematologic malignancies are cancers that affect the blood, bone marrow and lymph nodes and include different forms of leukemia and... read more
28May

UltraCell Insulation to open small R&D facility on Delevan Avenue

The company won $500,000 in last year's 43North competition and has moved its base of operations to Buffalo. Read more... read more
29Jun

The Pace Of Children’s Retail Innovation Speeds Up

Hope springs eternal. That sense of hope is a big part of childhood, and it applies as well to retail... read more
01Dec

Hoth Therapeutics Initiates Confirmatory Study for Lupus Treatment

Hoth Therapeutics, Inc....today announced initiating a confirmatory study, related to their proprietary AEA-loaded Z-pods in the treatment of Cutaneous Lupus... read more
20Mar

The World’s Most Innovative Companies of 2024

Candidly on the list. Read more >> read more